AbbVie unveils new data on solid tumour therapies - PharmaTimes Phase 1 and phase 2 results highlight promise of ADCs for hard-to-treat cancers

#oncology #AbbVie #solidtumourtherapies #ADCs #antibodydrugconjugate #ADCplatform #solidtumours #ESMO2025 #pancreaticcancer #colorectalcancer #solidtumourtypes #ADCcandidates #clinicaldevelopment #innovativetherapies #patientoutcomes #clinicalstrategies #regulatory
zurl.co/AmIT3